Market dialogue regarding a framework agreement for medicines and multi-dose.

Agder County, together with 23 municipalities and associated entities in the Agder region, plans to announce a framework agreement for medicines and multi-dose. According to the Procurement Regulations § 12-1 (1), the Contracting Authority is entitled to hold a market dialogue as part of the preparation of the procurement. The …

CPV: 33000000 Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte, 33600000 Arzneimittel, 33610000 Arzneimittel für Verdauungstrakt und Stoffwechsel, 33611000 Mittel bei säurebedingten Erkrankungen (Antacida), 33612000 Mittel bei funktionellen gastrointestinalen Störungen, 33615000 Antidiabetika, 33620000 Arzneimittel für Blut, Blut bildende Organe und das kardiovaskuläre System, 33621000 Arzneimittel für Blut und Blut bildende Organe, 33622000 Arzneimittel für das kardiovaskuläre System, 33622100 Herztherapiemittel, 33630000 Dermatika sowie Arzneimittel für das Muskel- und Skelettsystem, 33631000 Dermatika, 33632000 Arzneimittel für das Muskel- und Skelettsystem, 33640000 Arzneimittel für das Urogenitalsystem sowie Hormone, 33641000 Arzneimittel für das Urogenitalsystem sowie Sexualhormone, 33652200 Arzneimittel für endokrine Therapien, 33660000 Arzneimittel für Nervensystem und Sinnesorgane, 33661000 Arzneimittel für das Nervensystem, 33661700 Andere Mittel für das Nervensystem, 33662000 Arzneimittel der Sinnesorgane, 33670000 Arzneimittel für den Respirationstrakt, 33690000 Varia
Ausführungsort:
Market dialogue regarding a framework agreement for medicines and multi-dose.
Vergabestelle:
OFA IKS
Vergabenummer:
2025/6

1. Buyer

1.1 Buyer

Official name : OFA IKS
Legal type of the buyer : Body governed by public law, controlled by a local authority
Activity of the contracting authority : Public order and safety

2. Procedure

2.1 Procedure

Title : Market dialogue regarding a framework agreement for medicines and multi-dose.
Description : Agder County, together with 23 municipalities and associated entities in the Agder region, plans to announce a framework agreement for medicines and multi-dose. According to the Procurement Regulations § 12-1 (1), the Contracting Authority is entitled to hold a market dialogue as part of the preparation of the procurement. The objective of this market survey is to: Clarify whether the market can offer systems that cover the Contracting Authority's need Gain better insight into the possibility room and technological developments. Collect relevant information that can contribute to the design of the tender documentation. The contracting authority emphasises that input from the market is voluntary and not binding, and that there is no obligation to take into account the received input. We appreciate written input on the points in the document "Market Survey" and request feedback by 15.10.2025, 12:00.
Internal identifier : 2025/6

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33000000 Medical equipments, pharmaceuticals and personal care products
Additional classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33610000 Medicinal products for the alimentary tract and metabolism
Additional classification ( cpv ): 33611000 Medicinal products for acid related disorders
Additional classification ( cpv ): 33612000 Medicinal products for functional gastrointestinal disorders
Additional classification ( cpv ): 33615000 Medicinal products used in diabetes
Additional classification ( cpv ): 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system
Additional classification ( cpv ): 33621000 Medicinal products for the blood and blood-forming organs
Additional classification ( cpv ): 33622000 Medicinal products for the cardiovascular system
Additional classification ( cpv ): 33622100 Cardiac therapy medicinal products
Additional classification ( cpv ): 33630000 Medicinal products for dermatology and the musculo-skeletal system
Additional classification ( cpv ): 33631000 Medicinal products for dermatology
Additional classification ( cpv ): 33632000 Medicinal products for the musculo-skeletal system
Additional classification ( cpv ): 33640000 Medicinal products for the genitourinary system and hormones
Additional classification ( cpv ): 33641000 Medicinal products for the genitourinary system and sex hormones
Additional classification ( cpv ): 33652200 Endocrine therapy medicinal products
Additional classification ( cpv ): 33660000 Medicinal products for the nervous system and sensory organs
Additional classification ( cpv ): 33661000 Medicinal products for the nervous system
Additional classification ( cpv ): 33661700 Other nervous system medicinal products
Additional classification ( cpv ): 33662000 Medicinal products for sensory organs
Additional classification ( cpv ): 33670000 Medicinal products for the respiratory system
Additional classification ( cpv ): 33690000 Various medicinal products

2.1.2 Place of performance

Country : Norway
Anywhere in the given country
Additional information : OFA IKS is holding procurements on behalf of our participating municipalities, including Agder County, 23 municipalities and associated entities in the Agder region.

2.1.3 Value

Estimated value excluding VAT : 120 000 000 Norwegian krone

2.1.4 General information

Legal basis :
Directive 2014/24/EU

3. Part

3.1 Part technical ID : PAR-0000

Title : Market dialogue regarding a framework agreement for medicines and multi-dose.
Description : Agder County, together with 23 municipalities and associated entities in the Agder region, plans to announce a framework agreement for medicines and multi-dose. According to the Procurement Regulations § 12-1 (1), the Contracting Authority is entitled to hold a market dialogue as part of the preparation of the procurement. The objective of this market survey is to: Clarify whether the market can offer systems that cover the Contracting Authority's need Gain better insight into the possibility room and technological developments. Collect relevant information that can contribute to the design of the tender documentation. The contracting authority emphasises that input from the market is voluntary and not binding, and that there is no obligation to take into account the received input. We appreciate written input on the points in the document "Market Survey" and request feedback by 15.10.2025, 12:00.
Internal identifier : 2025/6

3.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33000000 Medical equipments, pharmaceuticals and personal care products
Additional classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33610000 Medicinal products for the alimentary tract and metabolism
Additional classification ( cpv ): 33611000 Medicinal products for acid related disorders
Additional classification ( cpv ): 33612000 Medicinal products for functional gastrointestinal disorders
Additional classification ( cpv ): 33615000 Medicinal products used in diabetes
Additional classification ( cpv ): 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system
Additional classification ( cpv ): 33621000 Medicinal products for the blood and blood-forming organs
Additional classification ( cpv ): 33622000 Medicinal products for the cardiovascular system
Additional classification ( cpv ): 33622100 Cardiac therapy medicinal products
Additional classification ( cpv ): 33630000 Medicinal products for dermatology and the musculo-skeletal system
Additional classification ( cpv ): 33631000 Medicinal products for dermatology
Additional classification ( cpv ): 33632000 Medicinal products for the musculo-skeletal system
Additional classification ( cpv ): 33640000 Medicinal products for the genitourinary system and hormones
Additional classification ( cpv ): 33641000 Medicinal products for the genitourinary system and sex hormones
Additional classification ( cpv ): 33652200 Endocrine therapy medicinal products
Additional classification ( cpv ): 33660000 Medicinal products for the nervous system and sensory organs
Additional classification ( cpv ): 33661000 Medicinal products for the nervous system
Additional classification ( cpv ): 33661700 Other nervous system medicinal products
Additional classification ( cpv ): 33662000 Medicinal products for sensory organs
Additional classification ( cpv ): 33670000 Medicinal products for the respiratory system
Additional classification ( cpv ): 33690000 Various medicinal products

3.1.2 Place of performance

Country : Norway
Anywhere in the given country
Additional information : OFA IKS is holding procurements on behalf of our participating municipalities, including Agder County, 23 municipalities and associated entities in the Agder region.

3.1.4 Value

Estimated value excluding VAT : 120 000 000 Norwegian krone

3.1.6 Procurement documents

Deadline for requesting additional information : 08/10/2025 10:00 +00:00

3.1.9 Further information, mediation and review

Review organisation : Agder Tingrett

8. Organisations

8.1 ORG-0001

Official name : OFA IKS
Registration number : 931832336
Department : OFA IKS
Postal address : Kjøita 40
Town : Kristiansand
Postcode : 4630
Country subdivision (NUTS) : Agder ( NO092 )
Country : Norway
Contact point : Hanne Hovde
Telephone : +47 99440142
Roles of this organisation :
Buyer

8.1 ORG-0002

Official name : Agder Tingrett
Registration number : 926723480
Town : Kristiansand
Postcode : 4614
Country subdivision (NUTS) : Agder ( NO092 )
Country : Norway
Roles of this organisation :
Review organisation

Notice information

Notice identifier/version : 4bb1761e-61a9-4c3e-8787-1c1a08a73f6b - 01
Form type : Planning
Notice type : Prior information notice or a periodic indicative notice used only for information
Notice dispatch date : 29/09/2025 11:00 +00:00
Notice dispatch date (eSender) : 29/09/2025 11:00 +00:00
Languages in which this notice is officially available : English
Notice publication number : 00638889-2025
OJ S issue number : 187/2025
Publication date : 30/09/2025
Estimated date of publication of a contract notice within this procedure : 30/10/2025